Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side Effect Clindamycin Effexor
DIARRHOEA 3.6% 1.7%
NAUSEA 3% 3.4%
DRUG INEFFECTIVE 2.6% 3.2%
DRUG HYPERSENSITIVITY 3.2% 1.1%
DEPRESSION 1.2% 2.9%
RASH 2.8% 0.9%
FATIGUE 2.3% 2.7%
PAIN 2.7% 2.1%
HEADACHE 1.8% 2.7%
ANXIETY 1.6% 2.7%
DIZZINESS 1.5% 2.7%
DRUG WITHDRAWAL SYNDROME 0% 2.4%
DYSPNOEA 2.3% 1.6%
INSOMNIA 0.8% 2.2%
PYREXIA 2.2% 0.8%
VOMITING 2.1% 1.8%
FEELING ABNORMAL 0.5% 2%
MALAISE 1.2% 1.9%
SUICIDAL IDEATION 0% 1.8%
FALL 1.1% 1.7%
WEIGHT INCREASED 0.5% 1.6%
ASTHENIA 1.5% 1.5%
PRURITUS 1.5% 0.8%
PNEUMONIA 1.4% 0.7%
ARTHRALGIA 1.3% 1.1%
CONDITION AGGRAVATED 0.9% 1.3%
PARAESTHESIA 0.6% 1.3%
TREMOR 0.5% 1.3%
ANAEMIA 1.3% 0.5%
SOMNOLENCE 0.5% 1.3%
RENAL FAILURE 1.3% 0%
ACUTE KIDNEY INJURY 1.3% 0%
WEIGHT DECREASED 1.2% 1.1%
CHEST PAIN 1.2% 0.9%
CONFUSIONAL STATE 0.6% 1.2%
HYPERHIDROSIS 0% 1.2%
ERYTHEMA 1.2% 0%
HYPERTENSION 0.9% 1.1%
BACK PAIN 1.1% 0.9%
ABDOMINAL PAIN 1.1% 0.8%
CELLULITIS 1.1% 0%
DRUG INTERACTION 1% 1%
PAIN IN EXTREMITY 1% 1%
COUGH 1% 0.7%
ABDOMINAL PAIN UPPER 1% 0.7%
HYPOTENSION 1% 0.6%
DIABETES MELLITUS 0% 1%
CHRONIC KIDNEY DISEASE 1% 0%
INJURY 1% 0%
OFF LABEL USE 0.9% 0.8%
CONSTIPATION 0.9% 0.8%
DECREASED APPETITE 0.9% 0.7%
DEATH 0.9% 0.6%
PULMONARY EMBOLISM 0.9% 0.5%
AGITATION 0% 0.9%
SEPSIS 0.9% 0%
SUICIDE ATTEMPT 0% 0.9%
CLOSTRIDIUM DIFFICILE INFECTION 0.9% 0%
URTICARIA 0.9% 0%
HYPERSENSITIVITY 0.9% 0%
GAIT DISTURBANCE 0.7% 0.8%
HYPOAESTHESIA 0.8% 0.7%
DEHYDRATION 0.8% 0.6%
OEDEMA PERIPHERAL 0.8% 0.6%
URINARY TRACT INFECTION 0.8% 0.6%
GASTROOESOPHAGEAL REFLUX DISEASE 0.8% 0.4%
WITHDRAWAL SYNDROME 0% 0.8%
CRYING 0% 0.8%
MEMORY IMPAIRMENT 0% 0.8%
DYSPHAGIA 0.8% 0%
RENAL FAILURE ACUTE 0.8% 0%
MUSCLE SPASMS 0.7% 0.7%
ABDOMINAL DISCOMFORT 0.7% 0.5%
MYALGIA 0.5% 0.7%
CHILLS 0.7% 0.5%
COMPLETED SUICIDE 0% 0.7%
CONVULSION 0% 0.7%
BLOOD PRESSURE INCREASED 0% 0.7%
DEEP VEIN THROMBOSIS 0.7% 0%
THROMBOCYTOPENIA 0.7% 0%
INFECTION 0.7% 0%
SINUSITIS 0.7% 0%
RASH MACULO-PAPULAR 0.7% 0%
LOSS OF CONSCIOUSNESS 0% 0.7%
DRUG DOSE OMISSION 0% 0.7%
IRRITABILITY 0% 0.7%
OVERDOSE 0% 0.7%
DISTURBANCE IN ATTENTION 0% 0.7%
ALOPECIA 0.5% 0.6%
VISION BLURRED 0% 0.6%
PALPITATIONS 0% 0.6%
DRUG EXPOSURE DURING PREGNANCY 0% 0.6%
NERVOUSNESS 0% 0.6%
AGGRESSION 0% 0.6%
AMNESIA 0% 0.6%
TYPE 2 DIABETES MELLITUS 0% 0.6%
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 0.6% 0%
EMOTIONAL DISTRESS 0.6% 0%
OSTEONECROSIS OF JAW 0.6% 0%
DYSPEPSIA 0.6% 0%
RESPIRATORY FAILURE 0.6% 0%
SWELLING FACE 0.6% 0%
PERIPHERAL SWELLING 0.6% 0%
CLOSTRIDIUM DIFFICILE COLITIS 0.6% 0%
PLEURAL EFFUSION 0.6% 0%
MYOCARDIAL INFARCTION 0% 0.5%
HALLUCINATION 0% 0.5%
HOT FLUSH 0% 0.5%
MIGRAINE 0% 0.5%
INTENTIONAL OVERDOSE 0% 0.5%
NIGHTMARE 0% 0.5%
DRY MOUTH 0% 0.5%
DRUG DEPENDENCE 0% 0.5%
PANIC ATTACK 0% 0.5%
VERTIGO 0% 0.5%
BLOOD CHOLESTEROL INCREASED 0% 0.5%
ANGER 0% 0.5%
DEPRESSED MOOD 0% 0.5%
CEREBROVASCULAR ACCIDENT 0% 0.5%
BALANCE DISORDER 0% 0.5%
ATRIAL FIBRILLATION 0.5% 0%
STAPHYLOCOCCAL INFECTION 0.5% 0%
OSTEOARTHRITIS 0.5% 0%
NEUTROPENIA 0.5% 0%
PANCYTOPENIA 0.5% 0%
SWELLING 0.5% 0%
BRONCHITIS 0.5% 0%
OSTEOMYELITIS 0.5% 0%
OROPHARYNGEAL PAIN 0.5% 0%
GENERAL PHYSICAL HEALTH DETERIORATION 0.5% 0%
NEUROPATHY PERIPHERAL 0.5% 0%
CARDIAC FAILURE CONGESTIVE 0.5% 0%
TACHYCARDIA 0.5% 0%
SYNCOPE 0.5% 0%
SEPTIC SHOCK 0.5% 0%
RENAL IMPAIRMENT 0.5% 0%
EXPOSURE DURING PREGNANCY 0.5% 0%
LYMPHADENOPATHY 0.5% 0%
HAEMOGLOBIN DECREASED 0.5% 0%
HEART RATE INCREASED 0% 0.4%
ABNORMAL BEHAVIOUR 0% 0.4%
TINNITUS 0% 0.4%
UNEVALUABLE EVENT 0% 0.4%
MUSCULAR WEAKNESS 0% 0.4%
INFLUENZA LIKE ILLNESS 0% 0.4%

New treatments are found every day. View current Clindamycin research studies and Effexor clinical trials

1